 Download the PDF version.
Journal of Sex & Marital Therapy Publishes Article on the Efficacy and Safety Of ZESTRA FOR WOMEN to Enhance Female Sexual Pleasure and Arousal
Wednesday January 15, 9:03 am ET
- Non-Prescription Zestra is Only Product of Its Kind to Successfully Complete Clinical Study By Independent Sexual Medicine Experts -
NEW YORK, Jan. 15 /PRNewswire/ -- The current issue of the Journal of Sex & Marital Therapy (Brunner-Routledge) reports on a randomized,
placebo-controlled, double blind crossover design trial that proved the efficacy and safety of Zestra for Women in women with and without Female
Sexual Arousal Disorder (FSAD). Zestra is the only product of its kind that has successfully completed a trial managed and conducted by independent
sexual medicine experts.
Zestra for Women is a botanical feminine massage oil formulated to enhance female sexual pleasure and arousal. In the study, 10 women with and 10
women without FSAD took part in the study. Safety was assessed by adverse event reports and primary efficacy by responses to a diary question
regarding satisfaction with arousal. Secondary efficacy instruments included remaining diary questions, recall-based questionnaires, global assessment
questions and a consumer-testing questionnaire.
Among the conclusions of the trial reported on in the article:
* Zestra for Women was well tolerated;
It improved level of desire, satisfaction with level of sexual arousal,
genital sensation, sexual pleasure, ability to have orgasms, and
enhancement of sexual experiences in normal and FSAD women while
eliminating the undesirable sexual side effects of SSRI antidepressants
in women.
"We are very pleased that Zestra for Women is the only women's topical consumer product that has been published in a major peer-reviewed medical
journal. No other non-prescription topical product for women is supported by a well-designed clinical trial," said Martin G. Crosby, founder,
president and CEO, QualiLife Pharmaceuticals, developer of Zestra for Women.
The 100% all-natural botanical ingredients of Zestra for Women, on the market since June 2002, are a proprietary blend of borage seed oil, evening
primrose oil, Angelica root extract, Coleus forskohlii extract, ascorbyl palmitate, dl-alpha tocopherol and natural fragrances. Each of Zestra's
botanical ingredients play highly complementary roles and work together naturally to safely and effectively enhance female sexual pleasure, sensation,
sensitivity and satisfaction.
Zestra for Women is available from participating doctors, pharmacies and other healthcare providers, by calling toll free 1-877-4-ZESTRA
(877-493-7872) or discreetly at the company's website: http://www.zestraforwomen.com.
QualiLife Pharmaceuticals, Inc., Charleston, S.C., focuses on developing and commercializing meaningful consumer products for the sexual health
marketplace.
CORPORATE CONTACT:
Martin G. Crosby, R.Ph.
Chairman & Chief Science Officer
Zestra Laboratories, Inc.
4055 Faber Place Drive, Suite 300
Charleston, SC 29405
843.402.0901 (phone)
843.402.0919 (fax)
www.zestraforwomen.com
Source: Zestra Laboratories, Inc.
Download the PDF version.
|
|
